Download
s40263-022-00969-3.pdf 552,12KB
WeightNameValue
1000 Titel
  • Evaluation of a Rapid Topiramate Titration Scheme for the Early Detection of Cognitive Side Effects
1000 Autor/in
  1. Witt, Juri-Alexander |
  2. Widman, Guido |
  3. Hansen, Niels |
  4. von Wrede, Randi |
  5. Elger, Christian |
  6. Helmstaedter, Christoph |
1000 Verlag
  • Springer International Publishing
1000 Erscheinungsjahr 2022
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2022-11-02
1000 Erschienen in
1000 Quellenangabe
  • 36(12):1325-1330
1000 Copyrightjahr
  • 2022
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1007/s40263-022-00969-3 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9712312/ |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Background!#!Topiramate (TPM) is effective for treating epilepsy, but executive dysfunction is a common side effect that could significantly affect everyday life. Additionally, previous studies have suggested that patients might be unaware of these changes.!##!Objective!#!To evaluate a rapid TPM titration scheme for the early detection of adverse cognitive side effects.!##!Methods!#!In this retrospective study, we assessed changes in objective cognitive performance (EpiTrack!##!Results!#!Using Bayesian statistics, analyses revealed decisive evidence of a negative effect on cognitive performance when TPM was introduced (BF 31480000000) independent of the titration speed (BF 0.739). When using a fast titration rate, deficits in executive function increased from a baseline of 53.1 to 73.5% at follow-up, and 55.1% experienced a statistically significant intraindividual decline. When using the standard titration scheme, impairments increased from 52.2 to 65.2%, with an intraindividual deterioration found in 52.2% of the patients.!##!Conclusion!#!Physicians might be able to detect adverse cognitive side effects sooner in epilepsy patients if TPM is administered using a faster titration rate while applying repeated cognitive assessments within days. This approach might help prevent any unnoticed intolerance and eventual negative consequences for the patient. Therefore, we recommend monitoring early on for adverse changes instead of withholding a potentially effective treatment option because of anticipated side effects.
1000 Sacherschließung
lokal Fructose/adverse effects [MeSH]
lokal Humans [MeSH]
lokal Epilepsy/drug therapy [MeSH]
lokal Original Research Article
lokal Psychology and Cognitive Sciences
lokal Retrospective Studies [MeSH]
lokal Bayes Theorem [MeSH]
lokal Topiramate/adverse effects [MeSH]
lokal Cognition [MeSH]
lokal Anticonvulsants/adverse effects [MeSH]
1000 Liste der Beteiligten
  1. https://orcid.org/0000-0001-5640-2592|https://orcid.org/0000-0002-3179-307X|https://orcid.org/0000-0002-1046-1113|https://orcid.org/0000-0002-9430-5037|https://orcid.org/0000-0002-2531-6701|https://orcid.org/0000-0002-6608-6244
1000 Hinweis
  • DeepGreen-ID: d6b9bc3d1dd44848948d28fc98fcaa38 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6488412.rdf
1000 Erstellt am 2024-10-03T11:31:22.105+0200
1000 Erstellt von 322
1000 beschreibt frl:6488412
1000 Zuletzt bearbeitet 2024-10-04T12:56:24.560+0200
1000 Objekt bearb. Fri Oct 04 12:56:24 CEST 2024
1000 Vgl. frl:6488412
1000 Oai Id
  1. oai:frl.publisso.de:frl:6488412 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source